Clinical trials: Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy, Borderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer
The investigators hypothesize that intensification of local therapy will lead to improvements in local control and survival in patients with unresectable and borderline resectable pancreatic cancer.
- Trial name
- NCT02207465
- Testing
- Radiotherapy, Abraxane
- Where
- 2 sites in United States
- Volunteers
- 42 people
- Sponsor
- Abramson Cancer Center at Penn Medicine